Search

Unfortunately, chemotherapy drugs cannot target only cancer cells. These drugs will also affect some normal cells. Normal cells recover faster than cancer cells though. This will let us damage more cancer cells with every... Read more

Four research projects led by Peter Mac have been awarded vital National Breast Cancer Foundation (NBCF) grants to continue world-class research into the prevention and treatment of breast cancer. Professor Paul James,... Read more

The Surveillance Study in Multi-organ Cancer Prone Syndromes (SMOC+) Trial is a longitudinal study investigating annual whole-body magnetic resonance imaging (MRI), and other early-detection diagnostic procedures, in individuals... Read more

Congratulations to Jeanne Tie, Penny Schofield, Tomas Kron and Belinda Parker who have recently earned the appointment of Honorary Professorial Fellow (Level E) with the Sir Peter MacCallum Department of Oncology, at the... Read more

Australian scientists have made a major discovery that could underpin the next generation of RNA-based therapeutics, and lead to more potent and longer-lasting RNA-based drugs with an even wider array of potential uses. In a... Read more

Peter Mac clinicians have described how a young patient with a rare, aggressive and only recently described form of acute myeloid leukaemia (AML) has responded to genomically-guided targeted therapy.Their report, which has... Read more